- Drugs
- Thursday, 19 Sep 2019
Aphria Inc Launches Plant Positivity Social Impact Platform with Evergreen
Aphria Inc. announced the launch of its new social impact platform, Plant Positivity. The company partnered with not-for-profit Evergreen which will create six new garden spaces at Evergreen Brick Works.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Innovent and Lilly Collaborate to Advance Novel Medicines
Feb 09, 2026
Sterilization Technologies Market is expected to reach US$ 9,109.08 million by 2030
Feb 16, 2024
MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry
Jun 27, 2020
Nasal Polyps Treatment Market Size will Escalate Rapidly in the Near Future 2020: Forecast 2027 by OptiNose US, Inc. , Regeneron Pharmaceuticals, Inc. , Merck KGaA , Pfizer, Inc.
Apr 09, 2021
UK's Cancer Survival Progress Slows Amid Unequal Outcomes and Service Delays
Aug 26, 2025
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
Mar 20, 2020
Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison
Nov 15, 2019